Literature DB >> 12837460

Effects of vitamin C on androgen receptor mediated actions in human prostate adenocarcinoma cell line LAPC-4.

Ming-Hsien Wang1, Yamilka Abreu-Delgado, Charles Y F Young.   

Abstract

OBJECTIVES: To examine the effects of vitamin C (VC) on androgen receptor (AR)-mediated functions in a human prostate cancer cell line, Los Angeles prostate cancer (LAPC-4). VC is an essential dietary substance in the maintenance and preservation of vital functions in humans. However, the role of VC in prostate cancer remains to be elucidated.
METHODS: Cell proliferation and the expression of two well-known androgen regulated proteins, prostate-specific antigen and human glandular kallikrein-2, were studied in the presence of VC.
RESULTS: In the presence of androgen and VC, both cell growth and the expression of prostate-specific antigen and human glandular kallikrein-2 proteins were decreased. Moreover, AR-mediated transcription activity of the prostate-specific antigen gene was suppressed with VC, similar to the phenomenon observed when cells were treated with hydrogen peroxide. These effects were reversed with catalase. However, additional studies did not reveal changes in the expression level of AR protein or its androgen-binding activity with the addition of VC.
CONCLUSIONS: The results of our study suggest that the pro-oxidant property of VC might be one of the mechanisms by which it modulates AR-mediated function in LAPC-4 cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12837460     DOI: 10.1016/s0090-4295(03)00136-5

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  2 in total

Review 1.  Vitamins and prostate cancer risk.

Authors:  Krishna Vanaja Donkena; R Jeffrey Karnes; Charles Y F Young
Journal:  Molecules       Date:  2010-03-12       Impact factor: 4.411

2.  Histone acetyltransferase 1 upregulates androgen receptor expression to modulate CRPC cell resistance to enzalutamide.

Authors:  Zhe Hong; Zhendong Xiang; Pan Zhang; Qiang Wu; Chengdang Xu; Xinan Wang; Guowei Shi; Zongyuan Hong; Denglong Wu
Journal:  Clin Transl Med       Date:  2021-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.